The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective

Psychiatria Danubina

Volumn 21, Issue 3, 2009, Pages 382-385

  Vuksan Ćusa, Bjanka ^a   Marčinko, Darko ^a   Šagud, Marina ^a   Jakovljević, Miro ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Bipolar disorder; Cardiovascular disease; Commorbidity; Effective treatment

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; VALPROIC ACID; ZIPRASIDONE;

ATRIOVENTRICULAR BLOCK; BEHAVIOR; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; CONFERENCE PAPER; DIABETES MELLITUS; DRUG THERAPY; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPOTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MENTAL DISEASE; MENTAL HEALTH; METABOLIC SYNDROME X; MORTALITY; ORTHOSTATIC HYPERTENSION; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; QT PROLONGATION; SIDE EFFECT; SINUS NODE DYSFUNCTION; T WAVE INVERSION; TORSADE DES POINTES; WEIGHT GAIN;

ANTICONVULSANTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; RISK FACTORS;

EID: 70350317516     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Akiskal HS, Fuller MA, Hirschfeld RM, Keck PE Jr., Ketter TA and Weisler RH. 2005. Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data, CNS Spectr 10 (6) suppl 1,11; discuss 12-3; quiz 14-15
2. Baptista N, Kin M, Beaulieu S and Baptista EA. 2002. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Pharmacopsychiatry 35 (6) : pp. 205-219. (Pubitemid 36061310)
3. Baune BT, Adrian I, Arolt V and Berger K. 2006. Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychother Psychosom 75:319-326. (Pubitemid 44200480)
4. Birkenaes AB, Sogaard AJ, Engh JA et al.2006. Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population. J Clin Psychiatry 67 (3):pp. 425-433.
5. Carney CP and Jones LE. 2006. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study, Psychosom Med 68 (5): pp. 684-691. (Pubitemid 44454636)
6. Dittmann S, Hennig-Fast K, Gerber S, Seemuller F, Riedel M, Emanulel SW, Langosch J, Engel RR, Moller HJ, Grunze HC.2008. Cognitive functioning in euthymic bipolar I and bipolar II patients. Bipolar Disord 10(8): 877-887.
7. Enger C, Weatherby L, Reynolds RF, Glasser DB and Walker AM. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis 2004; 192:19-27. (Pubitemid 38101693)
8. Glassman AH. 2005. Schizophrenia, antipsychotic drugs, and cardiovascular disease. J Clin Psychiatry 66: pp. 5-10 Suppl 6.
9. Hermann W, Lorenzl S, Obeid R.2007. Review of role of hyperhomocyteinemia and B-vitamin deficiency in neurological and psychiatric disorders-current evidence and preliminary recommendations. Fortschr Neurol Psychiatry 75 (9):515-527 (Pubitemid 47579752)
10. Isojarvi JI, Rattya J, Myllyla VV et al.(1998). Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 43 (4) : pp. 446-451. (Pubitemid 28231718)
11. Kasarskis EJ, Kuo CS, Berger R and Nelson KR. 1992. Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndromes, Arch Intern Med 152 (1): pp. 186-191.
12. Khan A, Schwartz K, Stern C et al. 2007. Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials. J Clin Psychiatry 68 (12) pp. 1828-1833.
13. Levine J, Sela BA, Osher Y, Belmaker RH. 2005. High homocysteine levels in young male schizophrenia and bipolar patients and in an animal model. Prog Neuropsychopharmacol Biol Psychiatry 29(7):1181-1191 (Pubitemid 41383518)
14. Limdi NA, Knowlton RK, Cofield S et al. 2007. Safety of rapid intravenous loading of valproate. Epilepsia 48 (3) pp. 478-483. (Pubitemid 46365200)
15. Mc Intyre RS. 2009. Overview of managing medical comorbidities in patients with severe mental illness. Journal of Clin Psych 70(6).pp 17.
16. Mitchell JE and Mackenzie TB. 1982. Cardiac effects of lithium therapy in man: a review. J Clin Psychiatry 43:47-51. (Pubitemid 12171391)
17. Newcomer JW. 2005. Second-generation (atypical) antipsychotics and metabolic effects. CNS Drugs 19:1-93.
18. Ninomiya JK, Italien G, Criqui MH et al. 2004. Association of the metabolic syndrome with history of myocardial infarction and stroke in The Third National Health and Nutritional Examination Survey. Circulation 109:42-46 (Pubitemid 38056019)
19. Osby U, Brandt L, Correia, N, Ekbom A and Sparen P.2001. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58 (9): pp. 844-850. (Pubitemid 32979302)
20. Pizzi C, Manzoli L, Mancini S and Costa GM. 2008. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J 29:1110-1117. (Pubitemid 351844893)
21. Reif A, Pfuhlmann B and Lesch KP. 2005. Homocysteinemia as well as methylentetrahydrofolate reductase polymorphism are associated with affective psychoses. Progress in Neuropsychopharmacol Biological Psychiatry 1162-1168. (Pubitemid 41383515)
22. Saadeddin SM, Habbab MA and Ferns GA.2002. Markers of inflammation and coronary artery disease. Med Sci Monit 8 (1): pp. RA5-RA12. (Pubitemid 34136335)
23. Sowden GL and Huffman JC.2009. The impact of mental illness on cardiac outcomes: A review for the cardiologist. International Journal of Cardiology 132(1): p.p. 30-37.
24. Tsai SY, Lee CH, Kuo CJ and Chen C.2005. A retrospective analysis of risk and protective factors for natural death in bipolar disorder. J Clin Psychiatry 66 (12): pp. 1586-1591. (Pubitemid 43068700)
25. Weber-Hamann B, Hentschel F, Kniest A et al. 2002. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 64 (2) :pp. 274-277. (Pubitemid 34260465)